Free Trial

IGM Biosciences (IGMS) Short Interest Ratio & Short Volume

$9.55
-0.49 (-4.88%)
(As of 05/24/2024 ET)

IGM Biosciences Short Interest Data

Current Short Interest
6,240,000 shares
Previous Short Interest
5,250,000 shares
Change Vs. Previous Month
+18.86%
Dollar Volume Sold Short
$60.09 million
Short Interest Ratio
21.6 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
59,020,000 shares
Float Size
20,890,000 shares
Short Percent of Float
29.87%
Today's Trading Volume
196,347 shares
Average Trading Volume
312,525 shares
Today's Volume Vs. Average
63%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling IGM Biosciences ?

Sign up to receive the latest short interest report for IGM Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

IGMS Short Interest Over Time

IGMS Days to Cover Over Time

IGMS Percentage of Float Shorted Over Time

IGM Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20246,240,000 shares $60.09 million +18.9%29.9%21.6 $9.63
4/15/20245,250,000 shares $49.40 million +0.6%25.0%19.4 $9.41
3/31/20245,220,000 shares $50.37 million +9.7%25.1%18.5 $9.65
3/15/20244,760,000 shares $50.65 million +5.5%22.9%16.4 $10.64
2/29/20244,510,000 shares $56.96 million -1.3%21.4%14.5 $12.63
2/15/20244,570,000 shares $70.38 million -2.6%21.9%14 $15.40
1/31/20244,690,000 shares $49.34 million -4.1%22.5%15.3 $10.52
1/15/20244,890,000 shares $53.50 million +4.7%23.5%14.2 $10.94
12/31/20234,670,000 shares $38.81 million +7.9%22.4%13.2 $8.31
12/15/20234,330,000 shares $28.58 million +5.4%20.9%12.5 $6.60
11/30/20234,110,000 shares $27.70 million -1.0%19.8%12.6 $6.74
11/15/20234,150,000 shares $24.49 million -17.0%20.0%13.9 $5.90
10/31/20235,000,000 shares $19.70 million -6.2%24.1%17.2 $3.94
10/15/20235,330,000 shares $23.51 million +1.5%25.7%20.6 $4.41
9/30/20235,250,000 shares $43.84 million -6.6%25.3%22.1 $8.35
9/15/20235,620,000 shares $41.36 million -0.4%27.1%21.3 $7.36
8/31/20235,640,000 shares $40.33 million +2.9%28.2%19 $7.15
8/15/20235,480,000 shares $42.74 million +12.3%27.4%17.1 $7.80
7/31/20234,880,000 shares $51.92 million -1.6%24.3%15.2 $10.64
7/15/20234,960,000 shares $49.60 million +2.3%26.1%15.8 $10.00
6/30/20234,850,000 shares $44.77 million +8.3%26.3%14.3 $9.23
6/15/20234,480,000 shares $45.07 million +2.5%24.2%13.4 $10.06
5/31/20234,370,000 shares $52.66 million +5.1%24.8%16.3 $12.05
5/15/20234,160,000 shares $57.32 million +2.5%23.7%18 $13.78
4/30/20234,060,000 shares $43.97 million +3.3%23.3%17.9 $10.83
4/15/20233,930,000 shares $43.66 million +7.4%22.8%18.2 $11.11
3/31/20233,660,000 shares $50.29 million -0.5%21.2%16.1 $13.74
3/15/20233,680,000 shares $69.59 million +3.7%21.1%20.5 $18.91
2/28/20233,550,000 shares $74.62 million -2.2%20.3%18.1 $21.02
2/15/20233,630,000 shares $87.05 million -4.5%20.8%17.4 $23.98
1/31/20233,800,000 shares $86.37 million +5.0%21.8%16.2 $22.73
1/15/20233,620,000 shares $91.69 million +4.3%20.9%15.1 $25.33
12/30/20223,470,000 shares $59.02 million -4.7%20.0%16 $17.01
12/15/20223,640,000 shares $67.34 million +12.7%20.9%15.8 $18.50
11/30/20223,230,000 shares $71.09 million -9.3%18.7%14.9 $22.01
11/15/20223,560,000 shares $92.63 million +5.6%20.6%16.2 $26.02
10/31/20223,370,000 shares $67.40 million -2.3%19.5%17.4 $20.00
10/15/20223,450,000 shares $71.35 million +3.6%19.9%18 $20.68
9/30/20223,330,000 shares $75.72 million +3.4%19.2%17 $22.74
9/15/20223,220,000 shares $71.55 million -3.9%18.6%16.2 $22.22
Biden replacement revealed? (Ad)

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

See his shocking evidence in this new report
8/31/20223,350,000 shares $65.02 million +3.1%20.1%15.3 $19.41
8/15/20223,250,000 shares $87.78 million -2.1%19.5%13.7 $27.01
7/31/20223,320,000 shares $53.49 million +1.2%21.1%12.2 $16.11
7/15/20223,280,000 shares $61.01 million +6.2%20.8%11.1 $18.60
6/30/20223,090,000 shares $55.71 million +4.4%19.6%9.1 $18.03
6/15/20222,960,000 shares $41.88 million -10.0%18.8%2.5 $14.15
5/31/20223,290,000 shares $55.21 million -6.3%20.9%2.8 $16.78
5/15/20223,510,000 shares $51.11 million -10.7%22.3%3 $14.56
4/30/20223,930,000 shares $65.79 million -9.0%27.0%3.4 $16.74
4/15/20224,320,000 shares $87.48 million -1.6%29.6%3.7 $20.25
3/31/20224,390,000 shares $117.34 million -3.1%N/A3.8 $26.73
3/15/20224,530,000 shares $60.79 million -1.7%30.8%14.3 $13.42
2/28/20224,610,000 shares $76.89 million -1.5%31.3%13.5 $16.68
2/15/20224,680,000 shares $80.96 million +2.2%31.7%13.8 $17.30
1/31/20224,580,000 shares $81.07 million +7.0%31.1%13.8 $17.70
1/15/20224,280,000 shares $93.65 million +3.6%N/A0 $21.88
12/31/20214,130,000 shares $121.13 million +14.1%28.0%15.4 $29.33
12/15/20213,620,000 shares $102.63 million -0.8%24.5%14.3 $28.35
11/30/20213,650,000 shares $182.21 million +1.1%24.8%20.9 $49.92
11/15/20213,610,000 shares $216.56 million +7.8%24.4%21.7 $59.99
10/29/20213,350,000 shares $157.18 million +2.8%22.9%21.6 $46.92
10/15/20213,260,000 shares $192.05 million +3.2%22.6%23.7 $58.91
9/30/20213,160,000 shares $207.80 million -1.3%21.9%24.1 $65.76
9/15/20213,200,000 shares $218.75 million -3.6%22.2%24.7 $68.36
8/31/20213,320,000 shares $236.42 million -0.3%23.1%24.2 $71.21
8/13/20213,330,000 shares $251.55 million +12.9%23.1%23 $75.54
7/30/20212,950,000 shares $200.63 million +1.0%20.6%19.6 $68.01
7/15/20212,920,000 shares $238.80 million -1.0%20.4%20.2 $81.78
6/30/20212,950,000 shares $245.44 million -3.6%20.6%18.4 $83.20
6/15/20213,060,000 shares $272.10 million +6.3%21.3%17.1 $88.92
5/28/20212,880,000 shares $214.99 million -3.4%20.1%14.7 $74.65
5/14/20212,980,000 shares $194.92 million -0.7%20.8%15.1 $65.41
4/30/20213,000,000 shares $215.37 million -0.3%21.0%15 $71.79
4/15/20213,010,000 shares $192.43 million -15.5%21.1%15.3 $63.93
3/31/20213,560,000 shares $267.21 million +47.7%24.9%18.2 $75.06
3/15/20212,410,000 shares $211.67 million +12.6%16.9%11.5 $87.83
2/26/20212,140,000 shares $179.65 million +10.3%15.0%7.4 $83.95
2/12/20211,940,000 shares $212.14 million -13.8%13.6%6.7 $109.35
1/29/20212,250,000 shares $214.52 million -8.5%15.8%7.6 $95.34
1/15/20212,460,000 shares $232.40 million -3.9%17.3%7.9 $94.47
12/31/20202,560,000 shares $233.42 million +18.0%18.0%8 $91.18
12/15/20202,170,000 shares $189.74 million -6.1%15.3%6.9 $87.44
11/30/20202,310,000 shares $156.34 million +5.5%17.6%7.7 $67.68
11/15/20202,190,000 shares $117.10 million +12.3%16.7%10.2 $53.47
10/30/20201,950,000 shares $107.13 million +29.1%14.9%9.8 $54.94
10/15/20201,510,000 shares $118.23 million -3.8%11.5%9.1 $78.30
9/30/20201,570,000 shares $115.88 million +1.3%12.0%11.2 $73.81
9/15/20201,550,000 shares $103.21 million +14.0%11.8%11.6 $66.59
8/31/20201,360,000 shares $58.48 million +3.0%10.4%12.6 $43.00
8/14/20201,320,000 shares $68.53 million +1.5%10.1%13.5 $51.92
Elon’s New Device is About to Shock the World (Ad)

Using this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.”

Click here to see the details because there’s a lot of money at stake.
7/31/20201,300,000 shares $65.34 million +20.4%10.0%13.2 $50.26
7/15/20201,080,000 shares $67.69 million +4.9%8.3%11.7 $62.68
6/30/20201,030,000 shares $69.98 million +38.4%7.9%10.8 $67.94
6/15/2020744,200 shares $46.54 million +2.3%5.7%8.3 $62.54
5/29/2020727,400 shares $47.27 million +9.3%5.6%7.9 $64.99
5/15/2020665,300 shares $38.64 million +1.1%5.1%6.5 $58.08
4/30/2020658,300 shares $36.06 million +5.7%5.1%5.6 $54.77
4/15/2020622,900 shares $34.88 million +11.5%4.8%5 $56.00
3/31/2020558,500 shares $31.56 million +24.7%4.3%4 $56.50
3/13/2020448,000 shares $29.04 million -0.8%3.5%2.8 $64.83
2/28/2020451,500 shares $23.32 million +1.1%3.5%2.7 $51.64
2/14/2020446,700 shares $22.52 million -22.0%3.5%2.8 $50.41
1/31/2020572,300 shares $30.62 million -14.7%4.5%3.7 $53.50
1/15/2020670,900 shares $28.82 million +45.6%5.3%4.4 $42.96
12/31/2019460,800 shares $18.35 million No Change3.7%3.4 $39.83

IGMS Short Interest - Frequently Asked Questions

What is IGM Biosciences' current short interest?

Short interest is the volume of IGM Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 6,240,000 shares of IGMS short. 29.87% of IGM Biosciences' shares are currently sold short. Learn More on IGM Biosciences' current short interest.

What is a good short interest ratio for IGM Biosciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IGMS shares currently have a short interest ratio of 22.0. Learn More on IGM Biosciences's short interest ratio.

What is a good short interest percentage for IGM Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 29.87% of IGM Biosciences' floating shares are currently sold short.

Is IGM Biosciences' short interest increasing or decreasing?

IGM Biosciences saw a increase in short interest in April. As of April 30th, there was short interest totaling 6,240,000 shares, an increase of 18.9% from the previous total of 5,250,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is IGM Biosciences' float size?

IGM Biosciences currently has issued a total of 59,020,000 shares. Some of IGM Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IGM Biosciences currently has a public float of 20,890,000 shares.

How does IGM Biosciences' short interest compare to its competitors?

29.87% of IGM Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to IGM Biosciences: KalVista Pharmaceuticals, Inc. (13.13%), Travere Therapeutics, Inc. (16.83%), Larimar Therapeutics, Inc. (6.11%), Astria Therapeutics, Inc. (10.24%), Applied Therapeutics, Inc. (3.91%), Oculis Holding AG (0.20%), Entrada Therapeutics, Inc. (9.54%), Fulcrum Therapeutics, Inc. (4.83%), Heron Therapeutics, Inc. (18.11%), Korro Bio, Inc. (2.68%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short IGM Biosciences stock?

Short selling IGMS is an investing strategy that aims to generate trading profit from IGM Biosciences as its price is falling. IGMS shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against IGM Biosciences?

A short squeeze for IGM Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IGMS, which in turn drives the price of the stock up even further.

How often is IGM Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IGMS, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:IGMS) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners